My Quote Request
No products added yet
6505-00-137-7745
20 Products
SERENTIL TABLETS
MESORIDAZINE BESYLATE TABLETS,USP
NSN, MFG P/N
6505001377745
NSN
6505-00-137-7745
SERENTIL TABLETS
MESORIDAZINE BESYLATE TABLETS,USP
NSN, MFG P/N
6505001377745
NSN
6505-00-137-7745
MFG
BOEHRINGER INGELHEIM PHARMACEUTICALS INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 25.000 MILLIGRAMS MESORIDAZINE ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,BOEHRINGER INGLEHEIM
Related Searches:
NDC00597-0023-01
MESORIDAZINE BESYLATE TABLETS,USP
NSN, MFG P/N
6505001377746
NSN
6505-00-137-7746
NDC00597-0023-01
MESORIDAZINE BESYLATE TABLETS,USP
NSN, MFG P/N
6505001377746
NSN
6505-00-137-7746
MFG
BOEHRINGER INGELHEIM PHARMACEUTICALS INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 100.000 MILLIGRAMS MESORIDAZINE ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,BOEHRINGER INGLEIM
Related Searches:
SERENTIL
MESORIDAZINE BESYLATE TABLETS,USP
NSN, MFG P/N
6505001377746
NSN
6505-00-137-7746
SERENTIL
MESORIDAZINE BESYLATE TABLETS,USP
NSN, MFG P/N
6505001377746
NSN
6505-00-137-7746
MFG
BOEHRINGER INGELHEIM PHARMACEUTICALS INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 100.000 MILLIGRAMS MESORIDAZINE ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,BOEHRINGER INGLEIM
Related Searches:
SERENTIL TABLETS
MESORIDAZINE BESYLATE TABLETS,USP
NSN, MFG P/N
6505001377746
NSN
6505-00-137-7746
SERENTIL TABLETS
MESORIDAZINE BESYLATE TABLETS,USP
NSN, MFG P/N
6505001377746
NSN
6505-00-137-7746
MFG
BOEHRINGER INGELHEIM PHARMACEUTICALS INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 100.000 MILLIGRAMS MESORIDAZINE ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,BOEHRINGER INGLEIM
Related Searches:
2998296
TETANUS AND DIPHTHERIA TOXOIDS FOR ADULT USE,ADSORBED,USP
NSN, MFG P/N
6505001381021
NSN
6505-00-138-1021
2998296
TETANUS AND DIPHTHERIA TOXOIDS FOR ADULT USE,ADSORBED,USP
NSN, MFG P/N
6505001381021
NSN
6505-00-138-1021
MFG
DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA
Description
SPECIAL FEATURES: BULK STOCK;CHEMICAL AND REACTION:DIPHTHERIA AND TETANUS TOXOIDS;ADSORBED
Related Searches:
8645249
TETANUS AND DIPHTHERIA TOXOIDS FOR ADULT USE,ADSORBED,USP
NSN, MFG P/N
6505001381021
NSN
6505-00-138-1021
8645249
TETANUS AND DIPHTHERIA TOXOIDS FOR ADULT USE,ADSORBED,USP
NSN, MFG P/N
6505001381021
NSN
6505-00-138-1021
MFG
DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA
Description
SPECIAL FEATURES: BULK STOCK;CHEMICAL AND REACTION:DIPHTHERIA AND TETANUS TOXOIDS;ADSORBED
Related Searches:
NDC00015-5436-60
HYDROFLUMETHIAZIDE AND RESERPINE TABLETS
NSN, MFG P/N
6505001383813
NSN
6505-00-138-3813
NDC00015-5436-60
HYDROFLUMETHIAZIDE AND RESERPINE TABLETS
NSN, MFG P/N
6505001383813
NSN
6505-00-138-3813
MFG
MEAD JOHNSON & COMPANY DBA MEAD JOHNSON NUTRITIONALS
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 50.000 MILLIGRAMS HYDROFLUMETHIAZIDE ACTIVE INGREDIENT AND 0.125 MILLIGRAMS RESERPINE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00725-0128-01
HYDROFLUMETHIAZIDE AND RESERPINE TABLETS
NSN, MFG P/N
6505001383813
NSN
6505-00-138-3813
NDC00725-0128-01
HYDROFLUMETHIAZIDE AND RESERPINE TABLETS
NSN, MFG P/N
6505001383813
NSN
6505-00-138-3813
MFG
CIRCA PHARMACEUTICAL CO INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 50.000 MILLIGRAMS HYDROFLUMETHIAZIDE ACTIVE INGREDIENT AND 0.125 MILLIGRAMS RESERPINE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
SALUTENSIN
HYDROFLUMETHIAZIDE AND RESERPINE TABLETS
NSN, MFG P/N
6505001383813
NSN
6505-00-138-3813
SALUTENSIN
HYDROFLUMETHIAZIDE AND RESERPINE TABLETS
NSN, MFG P/N
6505001383813
NSN
6505-00-138-3813
MFG
MEAD JOHNSON & COMPANY DBA MEAD JOHNSON NUTRITIONALS
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 50.000 MILLIGRAMS HYDROFLUMETHIAZIDE ACTIVE INGREDIENT AND 0.125 MILLIGRAMS RESERPINE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00574-0072-16
PROPYLENE GLYCOL,USP
NSN, MFG P/N
6505001384150
NSN
6505-00-138-4150
NDC00574-0072-16
PROPYLENE GLYCOL,USP
NSN, MFG P/N
6505001384150
NSN
6505-00-138-4150
MFG
CARDINAL HEALTH 200 LLC
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: PROPYLENE GLYCOL USP 1 LB (453.6 GM)
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 POUNDS OR 453.600 GRAMS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00143-1480-01
PROPYLTHIOURACIL TABLETS,USP
NSN, MFG P/N
6505001384225
NSN
6505-00-138-4225
NDC00143-1480-01
PROPYLTHIOURACIL TABLETS,USP
NSN, MFG P/N
6505001384225
NSN
6505-00-138-4225
MFG
BRISTOL-MYERS SQUIBB CO WESTWOOD-SQUIBB PHARMACEUTICALS DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 50.000 MILLIGRAMS PROPYLTHIOURACIL ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: PROPYLTHIOURACIL TABLETS USP 50 MG 100 TABLETS PER BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SUPPLEMENTARY FEATURES: D-DAY ITEM FOR DOD
THERAPEUTIC EQUIVALENT: LEDERLE LABORATORIES
Related Searches:
NDC00182-0086-01
PYRIDOXINE HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505001384995
NSN
6505-00-138-4995
NDC00182-0086-01
PYRIDOXINE HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505001384995
NSN
6505-00-138-4995
MFG
IVAX
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 50.000 MILLIGRAMS PYRIDOXINE HYDROCHLORIDE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: PYRIDOXINE HYDROCHLORIDE TABLETS USP 50 MG 100 TABLETS PER BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SUPPLEMENTARY FEATURES: D-DAY ITEM FOR DOD
Related Searches:
NDC00536-4408-01
PYRIDOXINE HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505001384995
NSN
6505-00-138-4995
NDC00536-4408-01
PYRIDOXINE HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505001384995
NSN
6505-00-138-4995
MFG
WATSON PHARMACEUTICALS INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 50.000 MILLIGRAMS PYRIDOXINE HYDROCHLORIDE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: PYRIDOXINE HYDROCHLORIDE TABLETS USP 50 MG 100 TABLETS PER BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SUPPLEMENTARY FEATURES: D-DAY ITEM FOR DOD
Related Searches:
NDC10135-0139-01
PYRIDOXINE HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505001384995
NSN
6505-00-138-4995
NDC10135-0139-01
PYRIDOXINE HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505001384995
NSN
6505-00-138-4995
MFG
MARLEX PHARMACEUTICAL
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 50.000 MILLIGRAMS PYRIDOXINE HYDROCHLORIDE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: PYRIDOXINE HYDROCHLORIDE TABLETS USP 50 MG 100 TABLETS PER BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SUPPLEMENTARY FEATURES: D-DAY ITEM FOR DOD
Related Searches:
NDC43567-0074-01
PYRIDOXINE HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505001384995
NSN
6505-00-138-4995
NDC43567-0074-01
PYRIDOXINE HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505001384995
NSN
6505-00-138-4995
MFG
MD PHARMACEUTICAL CO
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 50.000 MILLIGRAMS PYRIDOXINE HYDROCHLORIDE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: PYRIDOXINE HYDROCHLORIDE TABLETS USP 50 MG 100 TABLETS PER BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SUPPLEMENTARY FEATURES: D-DAY ITEM FOR DOD
Related Searches:
SPARKLETT5GAL
WATER,PURIFIED,USP
NSN, MFG P/N
6505001386722
NSN
6505-00-138-6722
MFG
MCKESSON HBOC INC. DBA MCKESSON HEALTH SYSTEMS
Description
PRIMARY CONTAINER CONTENT QUANTITY: 5.000 GALLONS
PRIMARY CONTAINER TYPE: BOTTLE, GLASS
Related Searches:
MD-76
DIATRIZOATE MEGLUMINE AND DIATRIZOATE SODIUM INJECTION,USP
NSN, MFG P/N
6505001387344
NSN
6505-00-138-7344
MD-76
DIATRIZOATE MEGLUMINE AND DIATRIZOATE SODIUM INJECTION,USP
NSN, MFG P/N
6505001387344
NSN
6505-00-138-7344
MFG
MALLINCKRODT INC ANESTHESIA PRODUCTS
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 PERCENTAGE, W/V DIATRIZOATE SODIUM ACTIVE INGREDIENT AND 66.000 PERCENTAGE, W/V MEGLUMINE DIATRIZOATE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: DIATRIZOATE MEGLUMINE-DIATRIZOATE SODIUM INJ 200 ML BT 10 BX
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
III SUPPLEMENTARY FEATURES: CONTAINS 4.48 MG SODIUM
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 200.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
NDC00003-0821-10
DIATRIZOATE MEGLUMINE AND DIATRIZOATE SODIUM INJECTION,USP
NSN, MFG P/N
6505001387344
NSN
6505-00-138-7344
NDC00003-0821-10
DIATRIZOATE MEGLUMINE AND DIATRIZOATE SODIUM INJECTION,USP
NSN, MFG P/N
6505001387344
NSN
6505-00-138-7344
MFG
SQUIBB E R AND SONS INC WORLD HQ
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 PERCENTAGE, W/V DIATRIZOATE SODIUM ACTIVE INGREDIENT AND 66.000 PERCENTAGE, W/V MEGLUMINE DIATRIZOATE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: DIATRIZOATE MEGLUMINE-DIATRIZOATE SODIUM INJ 200 ML BT 10 BX
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
III SUPPLEMENTARY FEATURES: CONTAINS 4.48 MG SODIUM
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 200.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
NDC00019-1317-09
DIATRIZOATE MEGLUMINE AND DIATRIZOATE SODIUM INJECTION,USP
NSN, MFG P/N
6505001387344
NSN
6505-00-138-7344
NDC00019-1317-09
DIATRIZOATE MEGLUMINE AND DIATRIZOATE SODIUM INJECTION,USP
NSN, MFG P/N
6505001387344
NSN
6505-00-138-7344
MFG
MALLINCKRODT INC ANESTHESIA PRODUCTS
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 PERCENTAGE, W/V DIATRIZOATE SODIUM ACTIVE INGREDIENT AND 66.000 PERCENTAGE, W/V MEGLUMINE DIATRIZOATE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: DIATRIZOATE MEGLUMINE-DIATRIZOATE SODIUM INJ 200 ML BT 10 BX
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
III SUPPLEMENTARY FEATURES: CONTAINS 4.48 MG SODIUM
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 200.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
NDC00024-0778-02
DIATRIZOATE MEGLUMINE AND DIATRIZOATE SODIUM INJECTION,USP
NSN, MFG P/N
6505001387344
NSN
6505-00-138-7344
NDC00024-0778-02
DIATRIZOATE MEGLUMINE AND DIATRIZOATE SODIUM INJECTION,USP
NSN, MFG P/N
6505001387344
NSN
6505-00-138-7344
MFG
STERLING-WINTHROP RESEARCH INSTITUTE A DIV OF STERLING DRUG INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 PERCENTAGE, W/V DIATRIZOATE SODIUM ACTIVE INGREDIENT AND 66.000 PERCENTAGE, W/V MEGLUMINE DIATRIZOATE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: DIATRIZOATE MEGLUMINE-DIATRIZOATE SODIUM INJ 200 ML BT 10 BX
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
III SUPPLEMENTARY FEATURES: CONTAINS 4.48 MG SODIUM
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 200.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
TOTAL PRIMARY CONTAINER QUANTITY: 10
